Literature DB >> 2027210

Transmetatarsal amputation: the role of adjunctive revascularization.

N Miller1, H Dardik, F Wolodiger, J Pecoraro, M Kahn, I M Ibrahim, B Sussman.   

Abstract

Over a 12-year period, 160 transmetatarsal amputations were performed in patients with peripheral vascular occlusive disease. The following groups were defined: group 1 - nonreconstructable disease (n = 40); group 2 - transmetatarsal amputation in conjunction with distal revascularization (n = 99); group 3 - reconstructable disease but transmetatarsal amputation performed without simultaneous revascularization (n = 21). There were nine early deaths in the entire series, for an operative mortality rate of 5.6%. The lowest rate of transmetatarsal amputation healing (24%) occurred in group 1. An 86% healing rate was achieved in group 3, but in seven cases (33%) some type of revascularization was required within 3 months of the amputation. In group 2 the healing rate was 62% but reached 83% where the bypass remained patent for at least 3 months after the amputation. Long-term patency rates also affected healing. Healing was not influenced by the number of local procedures (single vs multiple). The presence of severe infection or extensive necrosis necessitated open transmetatarsal amputation in 89 cases; the remaining 71 amputations involved primary closure. Since many patients were treated at a time when diagnostic modalities as well as the operative indications and techniques differed somewhat from the current practice, much of the information regarding group I patients in particular should be considered as a negative historical control and any conclusion from our data should be adjusted accordingly. Healing after amputation at the transmetatarsal level can be expected in the majority of instances in which revascularization can be performed with predictable patency, even when the standard criteria for performing such amputations are liberalized.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 2027210

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  6 in total

1.  Transmetatarsal amputation: three-year experience at Groote Schuur Hospital.

Authors:  B P Mwipatayi; N G Naidoo; P C Jeffery; C D Maraspini; M Z Adams; N Cloete
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

2.  Distal amputations: impact of the introduction of femorocrural and femoropedal arterial bypass.

Authors:  N R Borley; S Hettiaratchy; L Hands; J Collin
Journal:  Ann R Coll Surg Engl       Date:  1998-03       Impact factor: 1.891

3.  [Minor amputations for diabetic foot syndrome].

Authors:  G Rümenapf; W Lang; S Morbach
Journal:  Orthopade       Date:  2009-12       Impact factor: 1.087

4.  Re-amputation occurrence in the diabetic population in South Wales, UK.

Authors:  Rajani Kanade; Robert van Deursen; Jo Burton; Vanessa Davies; Keith Harding; Patricia Price
Journal:  Int Wound J       Date:  2007-10-24       Impact factor: 3.315

5.  Functional outcomes of transmetatarsal amputation in the diabetic foot: timing of revascularization, wound healing and ambulatory status.

Authors:  T Mandolfino; A Canciglia; M Salibra; D Ricciardello; G Cuticone
Journal:  Updates Surg       Date:  2016-01-29

6.  Review of Transmetatarsal Amputations in the Management of Peripheral Arterial Disease in an Asian Population.

Authors:  Ming Ngan Aloysius Tan; Zhiwen Joseph Lo; Soon Hong Lee; Rui Ming Teo; Wei Leong Glenn Tan; Sadhana Chandrasekar
Journal:  Ann Vasc Dis       Date:  2018-06-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.